Is it safe?
Can TEVA take a bad year?
Teva Pharmaceutical Industries Limited holds $1.13B more cash than debt, so a bad year is a question about profits, not about lenders.
$1.13B
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Debt / equity
- 0.32×
Debt / equity
- Annualised volatility
- 44%
Annualised volatility · roughly twice as jumpy as the market
Details›
- Total debtQ1 2026
- $2.61B
- Cash and short-term investments
- $3.74B
- Net cash
- $1.13B
- EBITDA, trailing twelve months
- $3.29B
- Operating profit, trailing twelve months
- $2.29B
- Debt / equity
- 0.32×
- Total debt / EBITDA
- 0.79×
- Annualised volatilitytwo years of daily moves
- 44%
- Worst drawdown on file
- −88%
- Below its 52-week high
- −0.37%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Drug Manufacturers - Specialty & Generic
Ranks #15 of 28 by Smart Score